SFP
LGND icon

Santa Fe Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Santa Fe Partners’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,276
Closed -$425K – 178
2015
Q4 		$425K Buy
+6,276
New +$387K 0.07% 361
2015
Q3 		– Sell
-54,031
Closed -$3.4M – 526
2015
Q2 		$3.4M Buy
+54,031
New +$2.95M 0.46% 58
2014
Q4 		– Sell
-21,091
Closed -$618K – 554
2014
Q3 		$618K Buy
+21,091
New +$700K 0.1% 350

Other funds holding LGND

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Santa Fe Partners's LGND Position: Q1 2016 in Review

Santa Fe Partners sold out of Ligand Pharmaceuticals (LGND) in Q1 2016, closing a stake of 6,276 shares — an estimated $425K sold.

Santa Fe Partners first reported a position in LGND in Q3 2014 and held it in 3 quarters. The position peaked at $3.4M in Q2 2015. 251 funds tracked by Wall St. Rank hold LGND as of Q1 2016.

  • Santa Fe Partners reported no remaining Ligand Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Santa Fe Partners sold 6,276 Ligand Pharmaceuticals shares in Q1 2016, an estimated $425K.
  • Santa Fe Partners first reported a position in Ligand Pharmaceuticals in Q3 2014 and held it in 3 quarters.
  • Santa Fe Partners's Ligand Pharmaceuticals position peaked at $3.4M in Q2 2015.
  • 251 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2016.

Based on Santa Fe Partners's 13F filing for Q1 2016.